Remimazolam
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Anesthesiology and Pain Medicine
Reference24 articles.
1. A placebo- and midazolam-controlled phase I single ascending dose study evaluating the safety, pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.;Antonik;Anesth Analg,2012
2. A placebo- and midazolam-controlled phase I single ascending dose study evaluating the safety, pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.;Wiltshire;Anesth Analg,2012
3. First administration to man of Org 25435, an intravenous anaesthetic: a phase 1 clinical trial.;Rigby-Jones;BMC Anesthesiol,2010
4. Administration to humans of ORG 21465, a water soluble steroid i.v. anaesthetic agent.;Sneyd;Br J Anaesth,1997
5. New i.v. anaesthetics.;Dundee;Br J Anaesth,1979
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative observation of the effectiveness and safety of remimazolam besylate versus dexmedetomidine in gastrointestinal surgery in obese patients;World Journal of Gastrointestinal Surgery;2024-05-27
2. The Rise of Remimazolam: A Review of Pharmacology, Clinical Efficacy, and Safety Profiles;Cureus;2024-03-30
3. Validation of the anesthetic effect of a mixture of remimazolam, medetomidine, and butorphanol in three mouse strains;Experimental Animals;2024
4. Advances in the Comparative Analysis of Remimazolam and Dexmedetomidine, Midazolam, and Propofol in Non-General Anesthesia-Assisted Sedation;Advances in Clinical Medicine;2024
5. Efficacy and safety of remimazolam compared with propofol in hypertensive patients undergoing breast cancer surgery: a single-center, randomized, controlled study;BMC Anesthesiology;2023-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3